Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

Erythematotelangiectatic Rosacea Clinical Trial

Official title:
Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Dose-Finding Study Investigating the Pharmacodynamics and Safety of Three Concentrations of CD07805/47 Topical Gel (0.07%, 0.18%, and 0.50%), Applied in Subjects With Moderate to Severe Erythematotelangiectatic Rosacea

Status Completed

Clinical Trial Summary

This is a randomized, double-blind, parallel-group, vehicle-controlled, dose-finding study to investigate the pharmacodynamics and the safety of three dosages of CD07805/47 topical gel (0.07%, 0.18%, and 0.50%), after a single application in subjects with a clinical diagnosis of stable moderate to severe erythematotelangiectatic rosacea. Subjects will be randomized in a 1:1:1:1 ratio to receive either one of three CD07805/47 topical gel concentrations (0.07%, 0.18%, or 0.50%) or Vehicle Gel. All subjects will be treated with a single application (once daily dosing for one day) of study medication.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00989014
Study type	Interventional
Source	Galderma R&D
Contact
Status	Completed
Phase	Phase 2
Start date	September 2009
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03708263` - Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea	N/A
Completed	`NCT02268474` - Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea	N/A
Completed	`NCT01756027` - Feasibility Study: Ulthera System for the Treatment of Rosacea	N/A
Completed	`NCT06331533` - Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea	Phase 4
Completed	`NCT02144181` - Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea	N/A
Recruiting	`NCT05360251` - Pulsed Dye Laser and Intense Pulsed Light Configured With Different Wavelength Bands in Improving Erythematotelangiectatic Rosacea	N/A
Completed	`NCT01045551` - Open Label Pilot Study of Apremilast in Treatment of Rosacea	Phase 2
Completed	`NCT00945373` - Combination Therapy for the Treatment of Rosacea	Phase 1
Completed	`NCT04153188` - Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea	Phase 4
Completed	`NCT02393937` - A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea	Phase 3
Completed	`NCT02052999` - Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients	Phase 2